Evidence map›Paper›PMID 26075184›Full record

ArticleFrontiers in oncology2015

Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy.

Paul Morel, Xiaodong Wu, Guillaume Blin, Stéphane Vialette, Ryan Flynn, Daniel Hyer, Dongxu Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Paul MorelLaboratoire Informatique Gaspard Monge (LIGM), UMR CNRS 8049, Université Paris-Est , Paris , France.
Xiaodong WuDepartment of Radiation Oncology, The University of Iowa , Iowa City, IA , USA ; Department of Electrical and Computer Engineering, The University of Iowa , Iowa City, IA , USA.
Guillaume BlinLaboratoire Informatique Gaspard Monge (LIGM), UMR CNRS 8049, Université Paris-Est , Paris , France ; UMR 5800, Laboratoire Bordelais de Recherche en Informatique (LaBRI), Université de Bordeaux , Talence , France.
Stéphane VialetteLaboratoire Informatique Gaspard Monge (LIGM), UMR CNRS 8049, Université Paris-Est , Paris , France.
Ryan FlynnDepartment of Radiation Oncology, The University of Iowa , Iowa City, IA , USA.
Daniel HyerDepartment of Radiation Oncology, The University of Iowa , Iowa City, IA , USA.
Dongxu WangDepartment of Radiation Oncology, The University of Iowa , Iowa City, IA , USA.
University of Iowa · USCentre National de la Recherche Scientifique · FRLaboratoire Bordelais de Recherche en Informatique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study describes a real-time spot weight adaptation method in spot-scanning proton therapy for moving target or moving patient, so that the resultant dose distribution closely matches the planned dose distribution. MATERIALS AND

methodsThe method proposed in this study adapts the weight (MU) of the delivering pencil beam to that of the target spot; it will actually hit during patient/target motion. The target spot that a certain delivering pencil beam may hit relies on patient monitoring and/or motion modeling using four-dimensional (4D) CT. After the adapted delivery, the required total weight [Monitor Unit (MU)] for this target spot is then subtracted from the planned value. With continuous patient motion and continuous spot scanning, the planned doses to all target spots will eventually be all fulfilled. In a proof-of-principle test, a lung case was presented with realistic temporal and motion parameters; the resultant dose distribution using spot weight adaptation was compared to that without using this method. The impact of the real-time patient/target position tracking or prediction was also investigated.

resultsFor moderate motion (i.e., mean amplitude 0.5 cm), D95% to the planning target volume (PTV) was only 81.5% of the prescription (RX) dose; with spot weight adaptation PTV D95% achieves 97.7% RX. For large motion amplitude (i.e., 1.5 cm), without spot weight adaptation PTV D95% is only 42.9% of RX; with spot weight adaptation, PTV D95% achieves 97.7% RX. Larger errors in patient/target position tracking or prediction led to worse final target coverage; an error of 3 mm or smaller in patient/target position tracking is preferred.

conclusionThe proposed spot weight adaptation method was able to deliver the planned dose distribution and maintain target coverage when patient motion was involved. The successful implementation of this method would rely on accurate monitoring or prediction of patient/target motion.

Indexed as

intensity-modulated proton therapyinterplay effectmotionspot scanningspot weight adaptation

Identifiers

PMID26075184
PMCPMC4447005
OpenAlexW1582456942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.